BCYC
Bicycle Therapeutics plc
NASDAQ · GBHealthcareBiotechnology
$4.17-0.95%
Price as of Jul 20, 2026
BCYC ownership
Bicycle Therapeutics plc ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
11
Net (3m)
-$60.5K
Insider trades by month Buys Sells
Apr
Jul
Oct
Jan
Apr
Jul
Context3-month price -21.6%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 7, 2026 | Perry Jennifer Scottofficer: Chief Operating Officer | Sell | 43 | $4.31 |
| Jul 7, 2026 | Thompson Travis Alvinofficer: Chief Financial Officer | Sell | 104 | $4.31 |
| Jul 7, 2026 | Skynner Michaelofficer: CHIEF SCIENTIFIC OFFICER | Sell | 1,859 | $4.27 |
| Jul 7, 2026 | Perry Jennifer Scottofficer: Chief Operating Officer | Sell | 1,036 | $4.27 |
| Jul 7, 2026 | Hannay Michael Charles Fergusonofficer: CHIEF PROD & SUPPLY CHAIN OFF | Sell | 1,506 | $4.27 |
| Jul 7, 2026 | Skynner Michaelofficer: CHIEF SCIENTIFIC OFFICER | Sell | 532 | $4.31 |
| Jul 7, 2026 | Lee Kevindirector, officer: CHIEF EXECUTIVE OFFICER | Sell | 1,737 | $4.31 |
| Jul 7, 2026 | Lee Kevindirector, officer: CHIEF EXECUTIVE OFFICER | Sell | 5,905 | $4.27 |
| Jul 7, 2026 | Hannay Michael Charles Fergusonofficer: CHIEF PROD & SUPPLY CHAIN OFF | Sell | 255 | $4.31 |
| Jul 7, 2026 | Thompson Travis Alvinofficer: Chief Financial Officer | Sell | 819 | $4.27 |
| Jul 7, 2026 | Perry Jennifer Scottofficer: Chief Operating Officer | Sell | 333 | $4.34 |
| Apr 6, 2026 | Perry Jennifer Scottofficer: Chief Operating Officer | Sell | 1,038 | $4.91 |
| Apr 6, 2026 | Thompson Travis Alvinofficer: Chief Financial Officer | Sell | 102 | $5.05 |
| Apr 6, 2026 | Perry Jennifer Scottofficer: Chief Operating Officer | Sell | 333 | $5.04 |
| Apr 6, 2026 | Thompson Travis Alvinofficer: Chief Financial Officer | Sell | 799 | $4.91 |
| Apr 6, 2026 | Hannay Michael Charles Fergusonofficer: CHIEF PROD & SUPPLY CHAIN OFF | Sell | 1,521 | $4.91 |
| Apr 6, 2026 | Hannay Michael Charles Fergusonofficer: CHIEF PROD & SUPPLY CHAIN OFF | Sell | 251 | $5.05 |
| Apr 6, 2026 | Lee Kevindirector, officer: CHIEF EXECUTIVE OFFICER | Sell | 5,967 | $4.91 |
| Apr 6, 2026 | Perry Jennifer Scottofficer: Chief Operating Officer | Sell | 37 | $5.05 |
| Apr 6, 2026 | Lee Kevindirector, officer: CHIEF EXECUTIVE OFFICER | Sell | 1,716 | $5.05 |
| Apr 6, 2026 | Skynner Michaelofficer: CHIEF SCIENTIFIC OFFICER | Sell | 525 | $5.05 |
| Apr 6, 2026 | Skynner Michaelofficer: CHIEF SCIENTIFIC OFFICER | Sell | 1,879 | $4.91 |
| Feb 4, 2026 | Thompson Travis Alvinofficer: Chief Financial Officer | Grant | 58,000 | $6.49 |
| Jan 6, 2026 | Hoppenot Hervedirector | Grant | 3,032 | — |
| Jan 6, 2026 | Riva Alessandrodirector | Grant | 14,761 | $7.08 |
| Jan 6, 2026 | Skynner Michaelofficer: CHIEF TECHNOLOGY OFFICER | Sell | 3,045 | $6.80 |
| Jan 6, 2026 | Sands Stephen H.director | Grant | 9,500 | — |
| Jan 6, 2026 | Hannay Michael Charles Fergusonofficer: CHIEF PROD & SUPPLY CHAIN OFF | Sell | 2,367 | $6.45 |
| Jan 6, 2026 | Milnes Alistairofficer: CHIEF OPERATING OFFICER | Grant | 50,000 | — |
| Jan 6, 2026 | Riva Alessandrodirector | Grant | 7,380 | — |
Source: BCYC SEC Form 4 filings, latest Jul 7, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their BCYC positions over the last 6 months (SEC Form 13F).
Increased
83
New positions
31
Reduced
45
Sold out
46
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | Unchanged | 10.9M | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 10.9M | Feb 17, 2026 |
| FCPM III SERVICES B.V. | Unchanged | 3.5M | May 15, 2026 |
| FCPM III SERVICES B.V. | Increased | 3.5M | Feb 17, 2026 |
| ARMISTICE CAPITAL, LLC | Increased | 3.4M | May 15, 2026 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | Increased | 3.3M | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Increased | 3.2M | Feb 17, 2026 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | Increased | 3.0M | Feb 11, 2026 |
| SIREN, L.L.C. | Unchanged | 2.0M | Feb 13, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 2.0M | May 13, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1.7M | Feb 10, 2026 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | Increased | 1.6M | Feb 17, 2026 |
| SIREN, L.L.C. | Reduced | 1.6M | May 14, 2026 |
| GSK PLC | New Position | 1.5M | Feb 12, 2026 |
| GSK PLC | Unchanged | 1.5M | May 14, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.